These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

145 related articles for article (PubMed ID: 16266727)

  • 1. Sublingual administration of Delta9-tetrahydrocannabinol/beta-cyclodextrin complex increases the bioavailability of Delta9-tetrahydrocannabinol in rabbits.
    Mannila J; Järvinen T; Järvinen K; Tervonen J; Jarho P
    Life Sci; 2006 Mar; 78(17):1911-4. PubMed ID: 16266727
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effects of RM-beta-CD on sublingual bioavailability of Delta9-tetrahydrocannabinol in rabbits.
    Mannila J; Järvinen T; Järvinen K; Tarvainen M; Jarho P
    Eur J Pharm Sci; 2005 Sep; 26(1):71-7. PubMed ID: 15955678
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The effect of hydroxypropyl-beta-cyclodextrin and sucrose on the sublingual absorption of midazolam in rabbits.
    Kaartama R; Turunen E; Toljamo K; Kokki H; Lehtonen M; Ranta VP; Savolainen J; Järvinen K; Jarho P
    Eur J Pharm Biopharm; 2012 May; 81(1):178-83. PubMed ID: 22321528
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Bioavailability of Δ⁹-tetrahydrocannabinol following intranasal administration of a mucoadhesive gel spray delivery system in conscious rabbits.
    Al-Ghananeem AM; Malkawi AH; Crooks PA
    Drug Dev Ind Pharm; 2011 Mar; 37(3):329-34. PubMed ID: 21244195
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Precipitation complexation method produces cannabidiol/beta-cyclodextrin inclusion complex suitable for sublingual administration of cannabidiol.
    Mannila J; Järvinen T; Järvinen K; Jarho P
    J Pharm Sci; 2007 Feb; 96(2):312-9. PubMed ID: 17051591
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Structure elucidation of the tetrahydrocannabinol complex with randomly methylated beta-cyclodextrin.
    Hazekamp A; Verpoorte R
    Eur J Pharm Sci; 2006 Dec; 29(5):340-7. PubMed ID: 16934442
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Determination of Delta9-tetrahydrocannabinol from rabbit plasma by gas chromatography-mass spectrometry using two ionization techniques.
    Mannila J; Lehtonen M; Järvinen T; Jarho P
    J Chromatogr B Analyt Technol Biomed Life Sci; 2004 Oct; 810(2):283-90. PubMed ID: 15380726
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cyclodextrins and chitosan derivatives in sublingual delivery of low solubility peptides: A study using cyclosporin A, alpha-cyclodextrin and quaternary chitosan N-betainate.
    Mannila J; Järvinen K; Holappa J; Matilainen L; Auriola S; Jarho P
    Int J Pharm; 2009 Oct; 381(1):19-24. PubMed ID: 19632311
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Studies on the metabolism of the Delta9-tetrahydrocannabinol precursor Delta9-tetrahydrocannabinolic acid A (Delta9-THCA-A) in rat using LC-MS/MS, LC-QTOF MS and GC-MS techniques.
    Jung J; Meyer MR; Maurer HH; Neusüss C; Weinmann W; Auwärter V
    J Mass Spectrom; 2009 Oct; 44(10):1423-33. PubMed ID: 19728318
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Oromucosal delta9-tetrahydrocannabinol/cannabidiol for neuropathic pain associated with multiple sclerosis: an uncontrolled, open-label, 2-year extension trial.
    Rog DJ; Nurmikko TJ; Young CA
    Clin Ther; 2007 Sep; 29(9):2068-79. PubMed ID: 18035205
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Fast-dissolving sublingual solid dispersion and cyclodextrin complex increase the absorption of perphenazine in rabbits.
    Turunen E; Mannila J; Laitinen R; Riikonen J; Lehto VP; Järvinen T; Ketolainen J; Järvinen K; Jarho P
    J Pharm Pharmacol; 2011 Jan; 63(1):19-25. PubMed ID: 21155811
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Ocular penetration of topical Delta9-tetrahydrocannabinol from rabbit corneal or cul-de-sac application site.
    Green KE; Kearse CE
    Curr Eye Res; 2000 Jul; 21(1):566-70. PubMed ID: 11035538
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pharmacokinetic study of a new synthetic MMP inhibitor (Ro 28-2653) after IV and oral administration of cyclodextrin solutions.
    Piette M; Evrard B; Frankenne F; Chiap P; Bertholet P; Castagne D; Foidart JM; Delattre L; Piel G
    Eur J Pharm Sci; 2006 Jun; 28(3):189-95. PubMed ID: 16520026
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Evaluation of the bioavailability of flurbiprofen and its beta-cyclodextrin inclusion complex in four different doses upon oral administration to rats.
    Muraoka A; Tokumura T; Machida Y
    Eur J Pharm Biopharm; 2004 Nov; 58(3):667-71. PubMed ID: 15451543
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Solid dispersions based on inulin for the stabilisation and formulation of delta 9-tetrahydrocannabinol.
    van Drooge DJ; Hinrichs WL; Wegman KA; Visser MR; Eissens AC; Frijlink HW
    Eur J Pharm Sci; 2004 Mar; 21(4):511-8. PubMed ID: 14998582
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Improvement of oral bioavailability of flurbiprofen from flurbiprofen/beta-cyclodextrin inclusion complex by action of cinnarizine.
    Tokumura T; Muraoka A; Machida Y
    Eur J Pharm Biopharm; 2009 Sep; 73(1):202-4. PubMed ID: 19442722
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of sublingual application of cannabinoids on intraocular pressure: a pilot study.
    Tomida I; Azuara-Blanco A; House H; Flint M; Pertwee RG; Robson PJ
    J Glaucoma; 2006 Oct; 15(5):349-53. PubMed ID: 16988594
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Enhancement of dissolution amount and in vivo bioavailability of itraconazole by complexation with beta-cyclodextrin using supercritical carbon dioxide.
    Hassan HA; Al-Marzouqi AH; Jobe B; Hamza AA; Ramadan GA
    J Pharm Biomed Anal; 2007 Oct; 45(2):243-50. PubMed ID: 17630246
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The effect of orally and rectally administered delta 9-tetrahydrocannabinol on spasticity: a pilot study with 2 patients.
    Brenneisen R; Egli A; Elsohly MA; Henn V; Spiess Y
    Int J Clin Pharmacol Ther; 1996 Oct; 34(10):446-52. PubMed ID: 8897084
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of vehicle upon in vitro transcorneal permeability and intracorneal content of Delta9-tetrahydrocannabinol.
    Kearse EC; Green K
    Curr Eye Res; 2000 Jun; 20(6):496-501. PubMed ID: 10980662
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.